Convalescent Plasma Update: Critical Need!

DES MOINES, Iowa (November 11, 2020) – LifeServe Blood Center, the sole provider of blood to more than 120 hospitals across Iowa, Nebraska, and South Dakota, is seeking community members who have tested positive for COVID-19 or have COVID-19 antibodies to donate convalescent plasma to meet the dramatically rising plasma needs of local hospitals.

As the number of daily COVID-19 cases in our region rises, so does the need for convalescent plasma (CCP) in local hospitals. This month has seen the highest CCP usage since the beginning of the pandemic. As patient hospitalizations continue to increase, it is projected that the amount of CCP needed for treatment will outpace the amount of donations of this lifesaving blood product.

“In the past fourteen days, LifeServe has provided more than 650 units of convalescent plasma to local hospitals” said Danielle West, Director of Marketing and Public Relations at LifeServe Blood Center. “We’re asking for the public’s help to spread the word and for people who have recovered from COVID to step up and donate. We expect the demand for this type of blood product to double in the coming week. Only plasma given to a community blood center such as LifeServe Blood Center can help local hospital patients. Plasma given to a paid plasma center is needed for pharmaceutical use. While that is important and needed, it will not immediately impact patients in our hospitals today.”

An eligible COVID-19 convalescent plasma donor will have tested positive for COVID-19 or have tested positive for the COVID-19 antibodies. Individuals who believe they had COVID but never received positive confirmation are encouraged to complete the CCP assessment form to determine eligibility. Additionally, all blood donors receive an antibody test as part of the donation process. Potential donors can schedule an appointment or seek more information here or by calling 800-287-4903.